Your browser doesn't support javascript.
loading
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation.
Magro, Fernando; Afonso, Joana; Lopes, Susana; Coelho, Rosa; Gonçalves, Raquel; Caldeira, Paulo; Lago, Paula; de Sousa, Helena Tavares; Ramos, Jaime; Gonçalves, Ana Rita; Ministro, Paula; Rosa, Isadora; Vieira, Ana Isabel; Andrade, Patrícia; Soares, João-Bruno; Carvalho, Diana; Sousa, Paula; Meira, Tânia; Lopes, Joanne; Moleiro, Joana; Dias, Cláudia Camila; Falcão, Amílcar; Geboes, Karel; Carneiro, Fatima.
Afiliação
  • Magro F; Department of Biomedicine, Unity of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal; MedInUP, Centre for Drug Discovery and Innovative Medicines, University of Porto, 4200 Porto, Portugal; Gastroenterology Department, Centro Hospitalar São João, Porto, Portug
  • Afonso J; MedInUP, Centre for Drug Discovery and Innovative Medicines, University of Porto, 4200 Porto, Portugal.
  • Lopes S; Gastroenterology Department, Centro Hospitalar São João, Porto, Portugal.
  • Coelho R; Gastroenterology Department, Centro Hospitalar São João, Porto, Portugal.
  • Gonçalves R; Gastroenterology Department, Hospital de Braga, Braga, Portugal.
  • Caldeira P; Gastroenterology Department, Centro Hospitalar do Algarve, Faro, Portugal.
  • Lago P; Gastroenterology Department, Centro Hospitalar do Porto, Porto, Portugal.
  • de Sousa HT; Gastroenterology Department, Centro Hospitalar do Algarve, Portimão, Portugal; Biomedical Sciences and Medicine Department, University of Algarve, Faro, Portugal; ABC-Algarve Biomedical Center, University of Algarve, Faro, Portugal.
  • Ramos J; Gastroenterology Department, Centro Hospitalar de Lisboa, Lisboa, Portugal.
  • Gonçalves AR; Gastroenterology Department, Centro Hospitalar Lisboa Norte, Lisboa, Portugal.
  • Ministro P; Gastroenterology Department, Hospital de S. Teotónio, Viseu, Portugal.
  • Rosa I; Gastroenterology Department, Instituto Português de Oncologia de Lisboa, Lisboa, Portugal.
  • Vieira AI; Gastroenterology Department, Hospital Garcia de Orta, Almada, Portugal.
  • Andrade P; Gastroenterology Department, Centro Hospitalar São João, Porto, Portugal.
  • Soares JB; Gastroenterology Department, Hospital de Braga, Braga, Portugal.
  • Carvalho D; Gastroenterology Department, Centro Hospitalar de Lisboa, Lisboa, Portugal.
  • Sousa P; Gastroenterology Department, Hospital de S. Teotónio, Viseu, Portugal.
  • Meira T; Gastroenterology Department, Hospital Garcia de Orta, Almada, Portugal.
  • Lopes J; Department of Pathology, Centro Hospitalar São João, Porto, Portugal.
  • Moleiro J; Gastroenterology Department, Instituto Português de Oncologia de Lisboa, Lisboa, Portugal.
  • Dias CC; Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS - Centre for Health Technology and Services Research, Porto, Portugal.
  • Falcão A; Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; CNC - Centre for Neuroscience and Cellular Biology, Coimbra, Portugal.
  • Geboes K; Department of Pathology, University Hospital of KU Leuven and UZ Gent, Leuven, Belgium.
  • Carneiro F; Department of Pathology, Centro Hospitalar São João, Porto, Portugal; Institute of Molecular Pathology and Immunology of the University of Porto [Ipatimup], University of Porto, Porto, Portugal.
EBioMedicine ; 21: 123-130, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28629912

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Complexo Antígeno L1 Leucocitário / Infliximab / Fatores Imunológicos / Anticorpos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Complexo Antígeno L1 Leucocitário / Infliximab / Fatores Imunológicos / Anticorpos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article